Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Fallopian Tube Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Bevacizumab 12Paclitaxel 11olaparib 10Specimen Handling 10Carboplatin 10Magnetic Resonance Spectroscopy 9liposomal doxorubicin 8Biopsy 5mirvetuximab soravtansine 4Topotecan 4Taxes 4Immunoglobulin G 4Gemcitabine 4Disulfides 4pembrolizumab 3cediranib 3Doxorubicin 3sarilumab 2niraparib 2cemiplimab 2Oxaliplatin 21-dodecylpyridoxal 2tremelimumab 1trastuzumab deruxtecan 1tocilizumab 1sotorasib 1peposertib 1pelcitoclax 1palbociclib 1nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fallopian Tube Neoplasms × Losartan × 30 days × Clear all
NCT07265739 2026-05-06

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

Massachusetts General Hospital

Phase 2 Not yet recruiting
27 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡